7 January 2018 in Biopolymers and Cell
Aim. Publication of gene expression raw data in public repositories made it possible to reuse these data for cross-experiment integrative analysis and make new insights into biological phenomena. However, data uploaded by independent contributors are not standardized, sometimes incomplete and need preprocessing before any further analysis. Hence, the aim of this study was to create a specialized database of gene expression profiles, particularly in preeclampsia-affected human placenta as a cause of high rate of morbidity and mortality all over the world with unknown etiology and pathogenesis. Methods. All experiment and sample metadata were automatically extracted from ArrayExpress database via Bioservices. NCBI database was used to supplement the missing data along with the corresponding scientific articles and authors personal data. The experimental sample attributes were standardized according to MeSH term dictionary and Experimental Factor Ontology. Results. A database of more than 1000 samples of normal and preeclampsia-affected human placenta was created and supplied with metadata containing information on biological specimen, diagnosis, gestational age, mode of delivery and other sample characteristics. Conclusion. The samples in our newly created database now contain metadata for them to be comparable. The biological samples may be arranged in different case-control groups of larger size than in individual datasets for statistically significant analysis.
20 January 2017 in bioRxiv
Advancements in both computer science and biotechnology opened way to unprecedented amount and variety of gene expression studies raw data in the open access. It is sometimes worth to rearrange and unite data from several similar gene expression studies into new case-control groups to test new hypothesis using available data. Unfortunately, most popular gene expression databases such as GEO and ArrayExpress were not designed to allow such cross-study procedures. In order to locate comparable samples in different studies numerous steps are required including gathering additional sample metadata and its standardization. Specialized databases are developed by investigators in their own fields of interest to reuse the processed data and create different case-control groups and test multiple hypothesis. Here we present detailed description of the specialized database creation along with its use case which is 32 gene expression cDNA microarray datasets on human placenta under conditions of pre-eclampsia containing expression data on more than 1000 biological samples. Samples contain sufficient metadata for them to be merged into relevant cross-experiment case-control groups for further integrative analysis.
21 January 2017 in bioRxiv
Publication of gene expression raw data in open access at online resources like NCBI or ArrayExpress made it possible to use these data for cross-experiment integrative analysis and make new insights into biological phenomena. However, most popular of the present online resources are meant to be archives rather than ready for immediate access and interpretation databases. Data uploaded by independent contributors is not standardized and sometimes incomplete and needs further processing before it is ready for the analysis. Hence, the need for a specialized database appears. Given in this article is the description of the database that was created after processing a collection of 33 relevant datasets on pre-eclampsia-affected human placenta. Data processing includes the choice of relevant experiments from ArrayExpress database, the experiment sample attributes standardization according to MeSH term dictionary and Experimental Factor Ontology and the completion of missing data using information from the corresponding articles and authors. A database of more than 1000 samples contains sufficient sample-wise metadata for them to be arranged into relevant case-control groups. Metadata includes information on biological specimen, donor’s diagnosis, gestational age, mode of delivery etc. The average size of these groups will be higher than it is in separate experiments. This will reduce experiment bias and enhance statistical accuracy of the subsequent analysis such as search for differentially expressed genes or inferring gene networks. The article concludes with the guidelines for the microarray experiment metadata uploading for future contributors.
16 October 2025 in bioRxiv
During gestation, the human placenta develops as a fetal organ in direct contact with maternal cells and tissues. Most pregnancy complications, such as preeclampsia and fetal growth restriction, have their roots early in pregnancy, most probably in dysregulation of placental development and/or disturbances in the interaction with maternal (immune) cells. Here, we applied an integrative analysis of open-access gene expression data on the human placenta, comparing expression levels between the first and second trimesters of healthy pregnancy, with a focus on differentially expressed genes related to immune processes. The holistic approach of our study revealed differentially expressed genes involved in the recognition and elimination of potential PAMPs and DAMPs, transendothelial cell migration, cytokine production, transplacental IgG transport, and maintenance of immune tolerance during the transition from the first to the second trimester of placental development. Most DEGs show an increased expression. Only a few genes,
DEFB1
,
SLPI
, and
LCN2,
which encode antimicrobial proteins, homeostatic chemokines, and a pleiotropic
PAEP
that maintains tolerance, display maximal expression in the first trimester, followed by further down-regulation. The cell types deconvolutions revealed the typical representation of placental cells.